Stock IMMNOV IMMUNOVIA AB
Add to a list
To use this feature you must be a member
Log inSign up

News Immunovia AB

Equities

IMMNOV

SE0006091997

Delayed Nasdaq Stockholm
Other stock markets
 11:06:26 2024-04-19 am EDT 		5-day change 1st Jan Change
1.798 SEK +0.56% Intraday chart for Immunovia AB +6.01% +1.47%
Apr. 09 Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test MT
Apr. 09 Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test
MT
Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
AQ
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study
CI
Immunovia announces updated financial calendar
AQ
Transcript : Immunovia AB, 2023 Earnings Call, Feb 21, 2024
Immunovia Publishes Full Year Report for 2023
AQ
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Invitation to Immunovia's Q4 presentation
AQ
Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs
AQ
Immunovia announces financial calendar for financial year 2024
AQ
Immunovia AB Elects Melissa Farina and Valerie Bogdan-Powers as New Board Members
CI
Bulletin from the extraordinary general meeting in Immunovia AB
AQ
Transcript : Immunovia AB, Q3 2023 Earnings Call, Nov 09, 2023
Immunovia Publishes Interim Report for January-September 2023
AQ
Immunovia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Immunovia Shares Surge on Discovery Study for New Pancreatic Cancer Test
MT
Immunovia successfully completes discovery phase of next-generation test development
AQ
Immunovia Successfully Completes Discovery Phase of Next-Generation Test Development
CI
Bilaga: Villkor för teckningsoptioner serie 2023:2034:1
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMMNOV Stock
  4. News Immunovia AB